CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Delisting notice
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 13,082 shares (to pay taxes)
- 4 Shares withheld for taxes CLO, SVP of Corp Dev gave up 4,721 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 73,150 shares (to pay taxes)
- 4 Shares withheld for taxes CLO, SVP of Corp Dev gave up 22,127 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, R&D and CMO gave up 7,694 shares (to pay taxes)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
- 4 Grant or award Director acquired 65,430 shares (grant or award)
Page 10 of 80 · 1,583 filings